Ektare, V., Simons, C., Johannesen, K., Krause, T., Zema, C. L., Buisman, L. R., Treur, M., Moura, A., Dasari, M., Verkaik, M., van de Wetering, G., Pronk, L., Pompen, M., Li, X., Contente, M., Knackstedt, C., & Hurst, M. (2026). A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective. Journal of Medical Economics, 29(1), 1595-1616. https://doi.org/10.1080/13696998.2026.2675850

Terron, M. C., Rossi, C., Krause, J., Schroen, B., Herum, K. M., & Nieuwenhoven, F. A. V. (2026). Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?Matrix Biology, 147, Article 102032. https://doi.org/10.1016/j.matbio.2026.102032

de Boer, R. A., Chaloupka, A., Cowley, B., Dominguez, F., Gentile, P., Halliday, B. P., Heymans, S., Jurcut, R. O., Zupan Meznar, A., Musella, F., & Merlo, M. (2026). Integrating genetics and phenotyping in clinical management of dilated and non-dilated left ventricular cardiomyopathy. European journal of heart failure, Article xuag224. Advance online publication. https://doi.org/10.1093/ejhf/xuag224

Allach, Y., de Jong, M. B. . L., Clephas, P. R. D., Abou Kamar, S., Rocca, H. P. B.-L., Handoko, M. L., van Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R. R. J., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2026). Pathophysiological analysis of serially measured plasma biomarkers, remote monitoring and clinical events, in symptomatic patients with moderate to severe chronic heart failure. IJC Heart and Vasculature, 65, Article 101970. https://doi.org/10.1016/j.ijcha.2026.101970

Fudim, M., Van Empel, V., Zehnder, T., Sauty, B., Esposito, C., Balazard, F., Mayer, I., Hallal, M., Loiseau, N., Weerts, J., Patel, M., Balu, S., Hintze, B., Torres, F., Micsinai, M., Rigolli, M., Kessler, P., Touzot, M., Lund, L. H., ... Butler, J. (2026). CONFIDENT-HFpEF: a machine learning-based risk stratification for mortality and hospitalization using multimodal real-world data. Esc heart failure, 13(4), Article xvag097. https://doi.org/10.1093/eschf/xvag097

Roubille, F., Kharlamov, J. A., Lenz, M., Madonna, R., Delmas, C., Schaubroeck, H., Morosin, M., Wojta, J., Vandenbriele, C., Kerneis, M., Lazaros, G., Evans, P., Huber, K., Hassager, C., Tarkin, J., Heymans, S., Christodorescu, R. M., Tsaban, G., Imazio, M., & Sionis, A. (2026). Inflammation in coronary syndromes in clinical practice: a clinical consensus statement of the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, the European Society of Cardiology Council on Basic Cardiovascular Science, and the European Society of Cardiology Council for Cardiology Practice. European Heart Journal: Acute Cardiovascular Care, Article zuag086. Advance online publication. https://doi.org/10.1093/ehjacc/zuag086

Verdonschot, J. A. J., Van Spaendonck-Zwarts, K. Y., Hellebrekers, D. M. E., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Garcia-Pavia, P., Haugaa, K. H., Jurcut, R., Kuchynka, P., Lopes, L. R., Mazzanti, A., Metra, M., Monserrat, L., Kaski, J. P., Pantazis, A., Prasad, S. K., Rosano, G., ... Van Tintelen, J. P. (2026). Genetic counselling implementation in dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the ESC, the ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Council on Cardiovascular Genomics. European Heart Journal, 47(24), 3040-3051. https://doi.org/10.1093/eurheartj/ehag159

Heymans, S. (2026). The dual face of lamin A/C cardiomyopathy: risk prediction of heart failure and arrhythmias. European Heart Journal, 47(24), 3149-3151. https://doi.org/10.1093/eurheartj/ehag215

Pinckaers, N. E. T., Blankesteijn, W. M., Peeters, R., Dijkstra, P., Tinnemans, R., Opperhuizen, A., van Schooten, F. J., & Vrolijk, M. (2026). Phenethylamines in pre-workout supplements alter arterial pressure, heart rate, and body temperature in rats. European Journal of Pharmacology, 1026, Article 178966. https://doi.org/10.1016/j.ejphar.2026.178966

Sunderland, N., Asselin, G., Henry, A., Nelson, C. P., Lemieux Perreault, L. P., Asselbergs, F. W., Boersma, E., Cappola, T. P., Chazara, O., Chutkow, W., Cyr, M. C., Gkatzionis, A., Gui, H., Haefliger, C., Hedman, Å. K., Hillege, H., Hyde, C. L., Kamanu, F. K., Kardys, I., ... Lumbers, R. T. (2026). Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study. Journal of the American College of Cardiology, 87(21), 2981-2992. https://doi.org/10.1016/j.jacc.2026.02.5093

Sliwa, K., Verdonschot, J. A. J., Hoevelmann, J., Macera, F., Cowley, B., Schamroth, A., de Marvao, A., Mbakwem, A., Farhan, H. A., Sensini, L., & Bauersachs, J. (2026). Cardio-obstetrics care: challenging scenarios in heart failure and future directions. European journal of heart failure. https://doi.org/10.1093/ejhf/xuag175

Bianchi, L., Afonso, L., Chendey, T., Modumudi, S., Minghini, A., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Efficacy and safety of sodium-glucose cotransporter inhibitors in hypertrophic cardiomyopathy: a systematic review. IJC Heart and Vasculature, 64, Article 101906. https://doi.org/10.1016/j.ijcha.2026.101906

Skouri, H., Abdin, A., Mullens, W., Bucciarelli Ducci, C., Starling, R. C., Van der Meer, P., Savarese, G., ben Gal, T., Bayes-Genis, A., Heymans, S., Klingel, K., Prasad, S. K., Farmakis, D., Chioncel, O., Ristic, A., Rosano, G., Seferovic, P., Ponikowiski, P., Metra, M., & Tschope, C. (2026). Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics: a clinical consensus statement of the Heart Failure Association of the ESC. Esc heart failure, 13(3), Article xvag115. https://doi.org/10.1093/eschf/xvag115

Pinckaers, N. E. T., Sawicka, P. D., Wopken, J. P., Blankesteijn, W. M., van Schooten, F.-J., Opperhuizen, A., Vrolijk, M., & Westerink, R. H. S. (2026). In vitro inhibition of monoamine transport by amphetamine-like pre-workout supplement ingredients. Toxicology, 523, Article 154442. https://doi.org/10.1016/j.tox.2026.154442

Sikking, M. A., Peisker, F., Maatz, H., Lopez-Anguita, N., Hazebroek, M. R., Henkens, M. T. H. M., Raafs, A. G., Heymans, A. B. M., Stroeks, S. L. V. M., Abdul Hamid, M. A., Li, X., Vicenzetto, C., Caforio, A. L. P., Brunner-La Rocca, H.-P., Knackstedt, C., van Paassen, P., van Empel, V. P. M., Hubner, N., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Improved outcome up to 10 years after intravenous immunoglobulin therapy in patients with dilated cardiomyopathy. European journal of heart failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag134

Kok, T. F., van Essen, B. J., Weerts, J., Yang, Y., Achten, A., Gansevoort, R. T., Bakker, S. J. L., van Empel, V., Damman, K., Boersma, E., Kardys, I., Voors, A. A., de Boer, R. A., & Suthahar, N. (2026). Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction. Mayo Clinic Proceedings, 101(6), 920-931. https://doi.org/10.1016/j.mayocp.2025.08.022

Peters, C., & Brunner-La Rocca, H.-P. (2026). Natriuretic peptides-a screening tool for heart failure?European heart journal - Quality of care & clinical outcomes, 12(4), 477-478. https://doi.org/10.1093/ehjqcco/qcag053

De Leeuw, J. C. B., Goërtz, Y. M. J., Wallin, M. K., Jaarsma, T., Friedrichsen, M., Jaarsma, P., Strömberg, A., Kurpas, D., Stefanicka-Wojtas, D., Geersing, G. J., de Graaf, E., Brunner-La Rocca, H. P., Janssen, D. J. A., Grice-Jackson, T., & RAPHAEL consortium (2026). Remote Monitoring Instruments in Palliative Care for People With Heart Failure: A Scoping Review. Journal of Pain and Symptom Management, 71(6), e696-e710. https://doi.org/10.1016/j.jpainsymman.2026.02.016

Di Feo, M. F., Paramonov, I., Borrel, L. M., Töpf, A., Hoischen, A., Beltran, S., Graessner, H., Vissers, L., de Voer, R., van Gijn, M., Balestrini, S., Lerche, H., Lesca, G., Gayathri, S. N., Ellwanger, K., Cossee, M., Perrin, A., Sarkozy, A., Bonne, G., ... SOLVE-RD Consortium (2026). The burden of TTN variants in the genomic era: analysis of 18,462 individuals from the Solve-RD consortium and general recommendations. Genetics in Medicine, 28(6), Article 101649. https://doi.org/10.1016/j.gim.2025.101649

Baggio, C., Cannata, A., Gasperetti, A., Ammirati, E., Gentile, P., Peretto, G., Savonitto, G., Cecere, A., Collini, V., Sikking, M., Mistrulli, R., Pagannone, E., Rossi, V. A., Schmidt, D., Compagnucci, P., Casella, M., Artico, J., Ciabatti, M., Fabris, E., ... Marco, M. (2026). Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study). Journal of the American Heart Association, 15(10), Article e046767. https://doi.org/10.1161/JAHA.125.046767

Buziau, A. M., Wesselius, A., Yu, E. Y.-W., Korver-Keularts, I. M. L. W., Visser, D., Steinbusch, L. K. M., Simons, P. I. H. G., van Greevenbroek, M. M. J., Dagnelie, P. C., Kooi, M. E., Eussen, S. J. P. M., Arts, I. C. W., van der Kallen, C. J. H., Schalkwijk, C. G., & Brouwers, M. C. G. J. (2026). Metabolite Erythritol in 24-Hour Urine Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study. Diabetes, 75(5), 762-771. https://doi.org/10.2337/db25-0881

Philip, M., Dumonceau, R. G., Citro, R., Cosyns, B., Donal, E., Erba, P. A., Gouriet, F., Iung, B., Kong, W. K. F., Lancellotti, P., Maggioni, A., Mancini, J., Popescu, B. A., Prendergast, B., Sambola, A., Sengupta, S. P., Timoteo, A., Tribouilloy, C., van Melle, J. P., ... Habib, G. (2026). Clinical characteristics, management and outcomes of enterococcal infective endocarditis: an ancillary study from the ESC-EORP EURO-ENDO registry. European heart journal - Quality of care & clinical outcomes, 12(3), 308-321. https://doi.org/10.1093/ehjqcco/qcaf145

de Gonzalo-Calvo, D., García-Hidalgo, M. C., Chatterjee, S., Thum, S., Ferreira, J. P., Rossignol, P., Girerd, N., Verdonschot, J. A. J., Heymans, S., Staessen, J. A., Cleland, J. G. F., Zannad, F., Thum, T., & Bär, C. (2026). Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE. European journal of internal medicine, 147, Article 106724. https://doi.org/10.1016/j.ejim.2026.106724

Pinckaers, N. E. T., Blankesteijn, W. M., Leenders, P., Weltjens, E., Opperhuizen, A., Van Schooten, F.-J., & Vrolijk, M. (2026). Potential Cardiovascular Risks of Phenethylamine Analogues in Food Supplements: Evidence from Vasocontraction of Rat Artery Segments. Cardiovascular Toxicology, 26(4), Article 36. https://doi.org/10.1007/s12012-026-10109-8

El Idrissi, A., Korver-keularts, I. M. L. W., Straat, R. J. M. H. E., & Beckers, E. A. M. (2026). Liberal versus restrictive transfusion in haemato-oncological patients undergoing autologous stem cell transplantation: A single-centre experience. Transfusion Medicine. Advance online publication. https://doi.org/10.1111/tme.70078

Weerts, J., Voorrips, S. N., Jeneson, J. A. L., Barandiaran Aizpurua, A., Mevenkamp, J., Sibeijn-Kuiper, A. J., Renken, R. J., Schroen, B. L. M., Knackstedt, C., Houben, A. J. H. M., van der Meer, P., Schrauwen-Hinderling, V. B., Westenbrink, B. D., & van Empel, V. P. M. (2026). Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo <SUP>31</SUP>P magnetic resonance spectroscopy. Esc heart failure, 13(2), Article xvaf035. https://doi.org/10.1093/eschf/xvaf035

Deissler, P. M., Rahm, A. K., Berkovitch, A., Müller, M. E., Sikking, M., Heymans, S., Langenberg, B., Moersdorf, M., Rieder, M., Nimani, S., Odening, K. E., Dichtl, W., Sabbag, A., Volders, P. G. A., & Ter Bekke, R. M. A. (2026). Temporal variability of the electromechanical window in long-QT syndrome and drug-induced QT prolongation: Value for enhanced arrhythmia-risk assessment. Heart Rhythm, 23(4), e636-e646. https://doi.org/10.1016/j.hrthm.2026.01.013

Glatz, J. F. C., Heather, L. C., Larsen, T. S., Nabben, M., & Luiken, J. J. F. P. (2026). The metabolic balancing act between fatty acid and glucose substrate use for optimal myocardial function: key role for membrane substrate transporters. American Journal of Physiology-heart and Circulatory Physiology, 330(4), H1195-H1207. https://doi.org/10.1152/ajpheart.00868.2025

Tie, H., Hou, M., Zhang, J., Hoes, M. F., Neumann, D., Luiken, J. J. F. P., & Wang, S. (2026). Comprehensive methodological evaluation of V-ATPase assembly in the context of cardiac lipid overload: implications for (endo)lysosomal function and autophagy. Autophagy, 22(4), 830-846. https://doi.org/10.1080/15548627.2025.2608963

de Jong, M. B. L., Allach, Y., Kamar, S. A., Clephas, P. R. D., Brunner-La Rocca, H. P., Handoko, M. L., van de Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2026). The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring. Journal of Cardiac Failure, 32(4), 718-728. https://doi.org/10.1016/j.cardfail.2025.04.014

Schianchi, F., Guns, J., Bouwman, F. G., Bogie, J. F. J., Nabben, M., Strzelecka, A., Van Leeuwen, R., Kapsokalyvas, D., Dennis, K. M. J. H., Heather, L. C., Wang, S., Glatz, J. F. C., Neumann, D., & Luiken, J. J. F. P. (2026). Lipid-induced S-palmitoylation of Insulin-Responsive Aminopeptidase (IRAP) drives the onset of insulin resistance in the heart. Cellular and Molecular Life Sciences, 83(1), Article 187. https://doi.org/10.1007/s00018-026-06179-0

Cami, E., Verghote, E., Pecetto, E., Gonzalez, A., Brakenhielm, E., Jones, E. A., & Van Empel, V. (2026). Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets. Current Heart Failure Reports, 23(1). Advance online publication. https://doi.org/10.1007/s11897-026-00745-0

Baugh, C. W., Gibson, C. M., Giannitsis, E., Morrow, D. A., Januzzi, J. L., Papendick, C., Brunner-La Rocca, H. P., Daniels, L. B., Palau, H., Visciola, L., & Than, M. (2026). Considerations for the Adoption of Digital Algorithms and Cardiovascular Decision-Support Tools in Clinical Practice. Critical Pathways in Cardiology, 25(1), e0412. https://doi.org/10.1097/HPC.0000000000000412

Schoonvelde, S. A. C., Zwetsloot, P.-P., Hirsch, A., Schinkel, A. F. L., Knackstedt, C., Germans, T., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., & Michels, M. (2026). Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy. Heart, 112(6), 333-340. Article 326217. https://doi.org/10.1136/heartjnl-2025-326217

Vajargah, K. K., Dib, M.-J., Tavolinejad, H., Zamani, P., Richards, A. M., Mann, D. L., Rietzschel, E., van Empel, V., Burgess, S., Cappola, T. P., & Chirinos, J. A. (2026). Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure, 14(3), Article 102771. https://doi.org/10.1016/j.jchf.2025.102771

Barbarossa, A., Van Slambrouck, J., Trivett, C., Kortleven, P., Vanluyten, C., Medina, A. M., Jin, X., Jannis, N., Ozsoy, B., Claes, S., Schols, D., Wylin, T., Moermans, K., Stegen, S., Rosello, A. P., Inci, I., De Leyn, P., Vanaudenaerde, B., Pirenne, J., ... Ceulemans, L. J. (2026). Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a Rat Ex Vivo Lung Perfusion Model. Transplant International, 39, Article 15993. https://doi.org/10.3389/ti.2026.15993

Ravassa, S., Girerd, N., Edelman, F., Lopez, B., Ferreira, J. P., Zurkan, D., Jose, G. S., Latasa, I., Pellicori, P., Cosmi, F., Petutschnigg, J., Heymans, S., Brunner-La Rocca, H.-P., Pieske, B., Delles, C., Clark, A. L., Diez, J., Zannad, F., Cleland, J. G. F., ... HOMAGE Trial Committees and Investigators (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), Article e70634. https://doi.org/10.1002/mco2.70634

Setjiadi, D., Delles, C., Kroon, A. A., Ressink, K., Bekers, O., Meex, S. J. R., Köhler, S., Kooman, J. P., Jansen, J. F. A., Brunner-La Rocca, H.-P., Wesselius, A., Houben, A. J. H. M., & van Greevenbroek, M. M. J. (2026). Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study. Journal of Hypertension, 44, 1329-1336. https://doi.org/10.1097/HJH.0000000000004265

Torfs, T., Veltrop, R. J. A., Lezzoche, G., Heymans, S. R. B., Verdonschot, J. A. J., & Nabben, M. (2026). Metabolic Dysregulation in Laminopathies: Implications for Heart Failure and Cardiac Health. Current Heart Failure Reports, 23(1), Article 6. https://doi.org/10.1007/s11897-025-00735-8

Vidula, M. K., Schurgers, L. J., Zhao, L., Dib, M.-J., Zhao, M., Wang, Z., Ebert, C., Salman, O., Azzo, J. D., Zamani, P., van Empel, V., Richards, A. M., Doughty, R., Javaheri, A., Mann, D. L., Rietzschell, E., Kammerhoff, K., Schafer, P., Seiffert, D. A., ... Chirinos, J. A. (2026). Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure. Circulation-Heart Failure, 19(2), 1-11. Article e012734. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012734

Keijsers, L. C. E. M., Peters, L. H. L., van Schayck, O. C. P., Muris, J. W. M., Boudewijns, E. A., Claessens, D., Willemsen, R. T. A., Salome, P. L., Boyne, J. J. J., Brunner-La Rocca, H.-P., van Pol, P. E. J., Jaarsma, T., Chavannes, N. H., Bonten, T. N., & Gidding-Slok, A. H. M. (2026). Development and psychometric properties of the 'Assessment of Burden of Chronic Conditions (ABCC) tool' for people with chronic heart failure (CHF): a mixed methods approach. Family Medicine and Community Health, 14(1), Article e003781. https://doi.org/10.1136/fmch-2025-003781

Raafs, A. G., Verdonschot, J. A. J., Knackstedt, C., Nijveldt, R., & Heymans, S. R. B. (2026). Clinical and prognostic impact of left atrial strain in non-ischemic cardiomyopathies. International Journal of Cardiovascular Imaging, 42(2), 175-193. https://doi.org/10.1007/s10554-025-03597-2

Heymans, A. B. M., van de Leur, R. R., Wang, P., González-López, E., Venner, M. F. G. H. M., Beelen, N. J., Muller, S. A., Mora-Ayestarán, N., Ramos, N., Faassen, I. M. E., Stroeks, S. L. V. M., Soria, M., van der Crabben, S. N., ter Bekke, R. M. A., van Es, R., Vernooy, K., te Riele, A. S. J. M., García-Pavía, P., Heymans, S. R. B., & Verdonschot, J. A. J. (2026). Detection of Titin-Associated Electrocardiography Features in Dilated Cardiomyopathy Using Conventional and Deep Neural Network Analysis. JACC: Clinical Electrophysiology, 12(2), 363-374. https://doi.org/10.1016/j.jacep.2025.10.006

Willemars, M. M. A., Sun, A., Wang, S., Simsek Papur, O., Brouns-Strzelecka, A., Van Leeuwen, R., Vanherle, S. J. V., Kapsokalyvas, D., Glatz, J. F. C., Neumann, D., Nabben, M., & Luiken, J. J. F. P. (2026). Phosphatidylinositol 4-Kinase IIIβ: A Therapeutic Target for Contractile Dysfunction in Hypertrophic Cardiomyocytes. International Journal of Molecular Sciences, 27(2), Article 595. https://doi.org/10.3390/ijms27020595

Peretto, G., Merlo, M., Ambrosi, A., Bacigalupi, E., Villatore, A., Molinari, L., Anguera, I., Claver, E., Dal Ferro, M., Suwalski, P., Spartalis, M., Verdonschot, J., Ciabatti, M., Martini, N., Zampieri, M., Paldino, A., Valeri, Y., Radesich, C., Lazzeroni, D., ... Sinagra, G. (2026). Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score. European Heart Journal, 47(1), 94-106. Article ehaf477. https://doi.org/10.1093/eurheartj/ehaf477

Srinivasan, A., de Lucio, M., Ghaffari, S., Jones, E. A. V., & Gomez, H. (2026). Computational Modeling Unveils the Impact of Tissue Growth and Vascular Remodeling on the Distribution of Interstitial Chemical Species. Annals of Biomedical Engineering. Advance online publication. https://doi.org/10.1007/s10439-026-04214-6

Lewis, G. D., Garcia-Pavia, P., Masri, A., Merkely, B., Nassif, M. E., Peña-Peña, M. L., Barriales-Villa, R., Bilen, O., Burroughs, M., Claggett, B., Costabel, J. P., de Barros Correia, E., Dybro, A. M., Kulac, I. J., Lakdawala, N. K., Mann, A., Maron, M. S., McGinnis, S., Nair, A., ... MAPLE-HCM Investigators (2026). Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy The MAPLE-HCM Randomized Clinical Trial. JAMA Cardiology. Advance online publication. https://doi.org/10.1001/jamacardio.2026.1730

Venner, M. F. G. H. M., Verdonschot, J. A. J., & Knackstedt, C. (2026). Letter to the editor: Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 442, Article 133886. https://doi.org/10.1016/j.ijcard.2025.133886

Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429

Gilani, K., Wei, W., Peters, C., Verket, M., Brunner-La Rocca, H.-P., Nicolis, E., Colombo, M., Marx-Schutt, K., Urovi, V., & Dumontier, M. (2026). CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment. BMC Medical Informatics and Decision Making, 26(1), Article 8. https://doi.org/10.1186/s12911-025-03272-5